SCHEMBL5823039

SCHEMBL5823039

CSc1nc(Nc2ccc(N3CCOCC3)cc2)cc(N2CCN(CC(=O)N3CCN(C)CC3)CC2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 4/20 0.50
NAMPT P43490 1/20 0.46
AURKB Q96GD4 3/20 0.43
ABL1 P00519 1/20 0.42
BCR P11274 1/20 0.42
CYP1A2 P05177 1/20 0.42
KMT2A Q03164 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
RAB9A P51151 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
RECQL P46063 1/20 0.42
NPC1 O15118 1/20 0.41
MTOR P42345 2/20 0.41
ZAP70 P43403 1/20 0.41
EML4 Q9HC35 1/20 0.41
ALK Q9UM73 1/20 0.41
KDR P35968 3/20 0.40
BRAF P15056 2/20 0.40
RAF1 P04049 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5820813 0.96 NAMPT (0.47) AURKANAMPTAURKBCYP1A2KMT2A
SCHEMBL5820251 0.94 CYP1A2 (0.45) AURKANAMPTAURKBCYP1A2KMT2A
SCHEMBL5816069 0.93 AURKA (0.43) AURKANAMPTAURKBCYP1A2KMT2A
SCHEMBL5823980 0.93 ZAP70 (0.49) AURKANAMPTAURKBCYP1A2KMT2A
SCHEMBL5821064 0.92 SMN1; SMN2 (0.44) AURKANAMPTAURKBCYP1A2KMT2A
SCHEMBL5821823 0.91 JAK3 (0.42) AURKANAMPTAURKBCYP1A2KMT2A
SCHEMBL5821753 0.91 AURKA (0.45) AURKANAMPTAURKBCYP1A2KMT2A
SCHEMBL5815028 0.90 RAB9A (0.46) AURKANAMPTAURKBCYP1A2KMT2A
SCHEMBL5820439 0.89 NAMPT (0.44) AURKANAMPTAURKBCYP1A2KMT2A
SCHEMBL5823587 0.89 JAK2 (0.43) AURKANAMPTAURKBCYP1A2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137706-A1 6-(4-SUBSTITUTED-ANILINO)PYRIMIDINE DERIVATIVES, METHOD FOR PREPARING THEREOF AND ANTIVIRAL PHARMACEUTICAL COMPOSITION COMPRISING THE SAME B & C BIOPHARM. CO., LTD. (KR) 2006-12-28 WO disclosed